Cargando…

Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus

BACKGROUND: Recently, basic and clinical studies have provided evidence supporting the relationship between circulating levels of fibroblast growth factor (FGF) 23 and the development of atherosclerosis. Given that diabetes is an established risk factor for lower extremity atherosclerotic disease (L...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xingxing, Hu, Xiang, Ma, Xiaojing, Su, Hang, Ying, Lingwen, Peng, Jiahui, Pan, Xiaoping, Bao, Yuqian, Zhou, Jian, Jia, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472967/ https://www.ncbi.nlm.nih.gov/pubmed/28619026 http://dx.doi.org/10.1186/s12933-017-0559-x

Ejemplares similares

Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
por: Zhang, Xiaoyan, et al.
Publicado: (2015)

The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes
por: He, Xingxing, et al.
Publicado: (2020)

Association of Advanced Glycation End Products With Lower-Extremity Atherosclerotic Disease in Type 2 Diabetes Mellitus
por: Ying, Lingwen, et al.
Publicado: (2021)

Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease
por: Shen, Yun, et al.
Publicado: (2020)

Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes
por: Hu, Xiang, et al.
Publicado: (2016)

Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population
por: Ying, Lingwen, et al.
Publicado: (2017)

Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
por: Shen, Yun, et al.
Publicado: (2013)

Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women
por: Xu, Yiting, et al.
Publicado: (2018)

Serum pigment epithelium-derived factor levels are independently correlated with the presence of coronary artery disease
por: Wang, Feifei, et al.
Publicado: (2013)

Comparative Agreement Analysis of Differences in 1,5-Anhydroglucitol, Glycated Albumin, and Glycated Hemoglobin A1c Levels between Fasting and Postprandial States in Steamed Bread Meal Test
por: Su, Hang, et al.
Publicado: (2017)

Relationship between serum osteocalcin level and carotid intima-media thickness in a metabolically healthy Chinese population
por: Luo, Yuqi, et al.
Publicado: (2015)

Postload Glycated Albumin as an Alternate Measure for Diabetes Screening in a Chinese Population
por: Su, Hang, et al.
Publicado: (2018)

Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death
por: Shen, Yun, et al.
Publicado: (2017)

Factors associated with lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus: A case-control study
por: Gao, Qingge, et al.
Publicado: (2016)

Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus
por: Wang, Shenqi, et al.
Publicado: (2013)

Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome
por: Ni, Jie, et al.
Publicado: (2013)

Serum 1,5-Anhydroglucitol to Glycated Albumin Ratio Can Help Early Distinguish Fulminant Type 1 Diabetes Mellitus from Newly Onset Type 1A Diabetes Mellitus
por: Ying, Lingwen, et al.
Publicado: (2020)

Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c
por: Ma, Xiaojing, et al.
Publicado: (2015)

Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway
por: Dou, Jianxin, et al.
Publicado: (2014)

Serum Fibroblast Growth Factor 23 Level and Liver Fat Content in MAFLD: A Community-Based Cohort
por: Cao, Weijie, et al.
Publicado: (2021)

Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease
por: Fetterman, Jessica L., et al.
Publicado: (2016)

Serum Levels of Fibroblast Growth Factor 19 Are Inversely Associated with Coronary Artery Disease in Chinese Individuals
por: Hao, Yaping, et al.
Publicado: (2013)

Cardiac risk factors of revascularization in chronic atherosclerotic lower extremity ischemia
por: Kim, Tae-Yoon, et al.
Publicado: (2013)

Chlamydia psittaci Pneumonia Complicated with Lower Extremity Atherosclerotic Occlusive Disease
por: He, YongHong, et al.
Publicado: (2023)

Classic Type 1 Diabetes Mellitus and Fulminant Type 1 Diabetes Mellitus: Similarity and Discrepancy of Immunological Characteristics and Cytokine Profile
por: Ying, Lingwen, et al.
Publicado: (2021)

Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
por: Mo, Yifei, et al.
Publicado: (2013)

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
por: Nelson, Adam J., et al.
Publicado: (2022)

Prescribing of Statins After Lower Extremity Revascularization Procedures in the US
por: Singh, Nikhil, et al.
Publicado: (2021)

Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US
por: Cannon, Christopher P., et al.
Publicado: (2021)

The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes
por: Li, Mei-Fang, et al.
Publicado: (2016)

Association Between Lower Extremity Arterial Disease and Various Sitting Positions
por: Asfour, Muhammed, et al.
Publicado: (2022)

Association Between Osseointegration of Lower Extremity Amputation and Mortality Among Adults
por: Hoellwarth, Jason Shih, et al.
Publicado: (2022)

Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics
por: Sørensen, Martin H., et al.
Publicado: (2020)

Comparison of coronary atherosclerotic disease burden between ST‐elevation myocardial infarction and non‐ST‐elevation myocardial infarction: Non‐culprit Gensini score and non‐culprit SYNTAX score
por: Tanaka, Takamasa, et al.
Publicado: (2020)

Triglycerides and Residual Atherosclerotic Risk
por: Raposeiras-Roubin, Sergio, et al.
Publicado: (2021)

Hepatic osteodystrophy with hypophosphataemia and elevated fibroblast growth factor‐23
por: Ng, Nicholas Beng Hui, et al.
Publicado: (2022)

Genetic Adaptations of an Island Pit-Viper to a Unique Sedentary Life with Extreme Seasonal Food Availability
por: Lu, Bin, et al.
Publicado: (2020)

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies
por: Ray, Kausik K., et al.
Publicado: (2019)

Contemporary follow-up imaging after endovascular repair of lower extremity atherosclerotic lesions
por: Michalska, Marta, et al.
Publicado: (2018)

Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes
por: Wegeberg, A. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bi76ul4nsqqcvpm5cieuf3kmcp